There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To report the biologic effect of intravitreal bevacizumab in patients with retinal
and iris neovascularization secondary to diabetes mellitus.